Chen Feng, Gu Zixue, Shi Zheng, Li Shiyun, Peng Rong
School of Basic Medical Sciences and School of Nursing, Chengdu University, Chengdu, Sichuan, China.
Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Front Nutr. 2025 Aug 20;12:1633788. doi: 10.3389/fnut.2025.1633788. eCollection 2025.
The current systematic research on the disease burden of Vitamin A deficiency in China is limited. To analyze the trends in the disease burden of Vitamin A Deficiency (VAD) in China from 1990 to 2021 and predict future trends from 2022 to 2050, providing a scientific basis for the prevention of VAD in China.
Based on the Global Burden of Disease (GBD) data, we extracted incidence, prevalence, and disability-adjusted life years (DALYs) for VAD in China from 1990 to 2021. The Joinpoint regression model was used to analyze temporal trends, calculating the estimated annual percentage change (EAPC) and its 95% confidence interval (CI). The Bayesian Age-Period-Cohort (BAPC) model was employed to integrate age, period, and cohort effects for predicting China's VAD disease burden from 2022 to 2050.
From 1990 to 2021, the Age-Standardized Incidence Rate (ASIR), Age-Standardized Prevalence Rate (ASPR), and Age-Standardized Disability-Adjusted Life Year Rate (ASR-DALYs) of VAD in China showed a significant downward trend, with Estimated Annual Percentage Change (EAPC) values of -5.31 (95% CI: -5.65 to -4.96), -5.31 (95% CI: -5.66 to -4.96), and -3.86 (95% CI, -4.84 to -2.86), respectively. The disease burden was higher in females than in males and higher in children than in adults. According to the BAPC model, the ASR-DALYs of VAD in China are expected to stabilize from 2022 to 2050, with a gradual decline from 3. 17/100,000 in 2022 to 2.70/100,000 in 2050. The ASIR and ASPR are projected to continue declining, with ASIR decreasing from 1,838. 15/100,000 in 2022 to 269.57/100,000 in 2050 and ASPR decreasing from 1,835.08/100,000 in 2022 to 267.89/100,000 in 2050.
While China's VAD burden has shown sustained reduction, continued attention is needed for children and women to address the "hidden hunger" of micronutrient deficiencies. Future efforts should strengthen nutritional interventions and health education to further mitigate the disease burden.
目前中国关于维生素A缺乏疾病负担的系统研究有限。分析1990年至2021年中国维生素A缺乏(VAD)疾病负担的趋势,并预测2022年至2050年的未来趋势,为中国预防VAD提供科学依据。
基于全球疾病负担(GBD)数据,提取1990年至2021年中国VAD的发病率、患病率和伤残调整生命年(DALYs)。采用Joinpoint回归模型分析时间趋势,计算估计年变化百分比(EAPC)及其95%置信区间(CI)。采用贝叶斯年龄-时期-队列(BAPC)模型整合年龄、时期和队列效应,以预测2022年至2050年中国的VAD疾病负担。
1990年至2021年,中国VAD的年龄标准化发病率(ASIR)、年龄标准化患病率(ASPR)和年龄标准化伤残调整生命年率(ASR-DALYs)呈显著下降趋势,估计年变化百分比(EAPC)值分别为-5.31(95%CI:-5.65至-4.96)、-5.31(95%CI:-5.66至-4.96)和-3.86(95%CI,-4.84至-2.86)。疾病负担女性高于男性,儿童高于成人。根据BAPC模型,预计2022年至2050年中国VAD的ASR-DALYs将趋于稳定,从2022年的3.17/10万逐渐下降至2050年的2.70/10万。ASIR和ASPR预计将继续下降,ASIR从2022年的1838.15/10万降至2050年的269.57/10万,ASPR从2022年的1835.08/10万降至2050年的267.89/10万。
虽然中国的VAD负担持续下降,但仍需持续关注儿童和妇女,以解决微量营养素缺乏的“隐性饥饿”问题。未来应加强营养干预和健康教育,以进一步减轻疾病负担。